Sign in

CIK 0001501989

  • Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
273521219
Phone
+1 650-515-3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Exercise or conversion CSO, Head Res.&Non-Clin. Dev. acquired 5,130 shares (option exercise)
  2. 4 Open-market sale Chief Financial Officer sold 2,500 shares at $20.58 ($51,450)
  3. 4 Open-market sale President and CEO sold 14,340 shares at $20.60 ($295,404)
  4. 4 Open-market sale President and CEO sold 14,342 shares at $19.86 ($284,832)
  5. 4 Open-market sale Chief Financial Officer sold 2,500 shares at $20.00 ($50,000)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Other disposition 10% owner disposed of 1,000,000 shares (other)
  9. 4 Open-market sale President and CEO sold 19,120 shares at $24.13 ($461,366)
  10. 4 Open-market sale CSO, Head Res.&Non-Clin. Dev. sold 48,368 shares at $24.34 ($1,177,277)
  11. 4 Open-market sale Director sold 10,000 shares at $24.27 ($242,680)
  12. 4 Open-market sale President and CEO sold 9,562 shares at $18.57 ($177,566)
  13. 4 Open-market sale 10% owner sold 24,777 shares at $24.34 ($603,072)
  14. 4 Open-market sale Chief Financial Officer sold 2,500 shares at $18.10 ($45,250)
  15. 4 Open-market sale Director sold 5,000 shares at $17.30 ($86,476)
  16. 4/A Open-market sale President and CEO sold 9,930 shares at an average $17.33 ($172,054)
  17. 4/A Open-market sale President and CEO sold 18,756 shares at an average $17.50 ($328,260)
  18. 4 Open-market sale 10% owner sold 20,000 shares at $18.00 ($360,000)
  19. 4 Open-market sale Chief Financial Officer sold 2,500 shares at $17.17 ($42,925)
  20. 4 Open-market sale President and CEO sold 9,930 shares at $17.32 ($171,988)

Page 14 of 20 · 400 filings